Manufacturer record
Healers Lab Unit II: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
18 batches manufactured by Healers Lab Unit II (Himachal Pradesh) were declared Not of Standard Quality between November 2022 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
18 records linked to Healers Lab Unit II in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ofloxacin Tablets I.P. 400 mg | OFB-506Mfg 2023-03 · Exp 2026-02 | Dissolution testDissolution | SDT&RL, BhubaneswarState lab | Dec 2025 |
| Calcium & Vitamin D3 Tablets IP (500 mg/250IU) | CDA-583Mfg 2025-03 · Exp 2027-02 | The sample does not comply as per I.P. 2022 with respect to The test for Dissolution of Calcium.Dissolution | RDTL, GuwahatiCDSCO lab | Dec 2025 |
| Calcium & Vitamin D3 Tablets IP (500 mg/250IU) | CDA-586Mfg 2025-03 · Exp 2027-02 | The sample does not comply as per I.P. 2022 with respect to the Test for "Assay" of Vitamin D3 and "Dissolution" for Calcium.Assay | RDTL, GuwahatiCDSCO lab | Oct 2025 |
| Pantoprazole Tablets I.P.. | PAA-528Mfg 2025-04 · Exp 2027-03 | sample does not comply as per I.P. 2022 with respect to the test for "Dissolution in buffer stage" For Pantoprazole.Dissolution | RDTL, GuwahatiCDSCO lab | Sep 2025 |
| Telmisartan Tablets IP 40mg | TLL-507Mfg 2025-01 · Exp 2026-12 | Dissolution of TelmisartanDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Telmisartan Tablets IP 40 mg | TLL-505Mfg 2025-01 · Exp 2026-12 | Dissolution of TelmisartanDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Telmisartan Tablets IP 40 mg | TLL-505Mfg 2025-01 · Exp 2026-12 | Dissolution of TelmisartanDissolution | RDTL, GuwahatiCDSCO lab | Jul 2025 |
| Telmisartan Tablets IP 40 mg | TLL-504Mfg 2025-01 · Exp 2026-12 | Dissolution of TelmisartanDissolution | RDTL GuwahatiCDSCO lab | Jun 2025 |
| Telmisartan Tablets IP 40 mg | TLL-503Mfg 2025-01 · Exp 2026-12 | Dissolution of TelmisartanDissolution | RDTL GuwahatiCDSCO lab | Jun 2025 |
| Ursodeoxycholic acid Tablets IP 300 mg | UDS-501Mfg 2024-08 · Exp 2026-07 | The sample does not confirm to claim as per IP 2022 in respect to the Dissolution of Ursodiol ( Ursodeoxycholic Acid)Dissolution | DTL Baddi Distt. SolanState lab | May 2025 |
| Pantoprazole Tablets I.P.. | PAA-507Mfg 2023-06 · Exp 2025-05 | The sample Does not complies conforms to Manufacturer Specification with respect to the above tests only.Other | RDTL GuwahatiCDSCO lab | May 2024 |
| Pantoprazole Tablets I.P.. | PAA-507Mfg 2023-06 · Exp 2025-05 | The sample Does not complies conforms to Manufacturer Specification with respect to the above tests only.Other | RDTL GuwahatiCDSCO lab | May 2024 |
| Levocetirizine Tablets IP | LVU-515Mfg 2023-06 · Exp 2025-05 | Identification and Assay of Levocetirizine HydrochlorideAssay | RDTL ChandigarhCDSCO lab | Jan 2024 |
| Paracetamol Tablets IP 500 mg | PRS-520Mfg 2022-08 · Exp 2025-07 | DissolutionDissolution | RDTL ChandigarhCDSCO lab | Nov 2023 |
| PANTOPRAZOLE TABLETS I.P. (40 mg) | PAA-504Mfg 2023-01 · Exp 2024-12 | Dissolution in Acid Stage & DescriptionDissolution | RDTL GuwahatiState lab | Oct 2023 |
| Glimepiride Tablets IP 1 mg | GPG-531Mfg 2023-04 · Exp 2025-03 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Oct 2023 |
| Glimepiride Tablets IP 1 mg | GPU-511Mfg 2021-09 · Exp 2023-08 | Dissolution and Related SubstancesDissolution | RDTL ChandigarhCDSCO lab | Feb 2023 |
| Tolperisone Hydrochloride Tablets 150 mg | TSB-501Mfg 2021-12 · Exp 2023-11 | AssayAssay | RDTL ChandigarhCDSCO lab | Nov 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.